The operating environment for medium-sized generic drug manufacturers is changing rapidly as the industry matures and growth focuses on new market opportunities.

Consolidation continues to affect companies, as acquisition becomes the instrument of choice in the drive for market share.

But…
Who are the medium-sized companies of note?
How well do they perform?
What products do they produce?
Where are they located?

This report will tell you! The pace of corporate consolidation grows ever faster - eight significant acquisitions were announced in 2006:
...
Target
Andrx, Mayne Pharma, Betapharm, Pliva, Matrix, Zentiva, Terapia, Hemofarm, Sindan Buyer
Watson, Hospira, Dr Reddy's, Barr Pharmaceutical, Mylan Labs, sanofi-aventis, Ranbaxy, Stada Arzneimittel, Actavis

Increasingly the industry is being rationalised and dominated by fewer and fewer large players. Teva and Sandoz may be fighting it out for the top spot but the speed of change is seeing the corporate landscape change continuously.

And what about 2007?
All generic companies are operating in increasingly crowded and competitive environments as far as the traditional high value markets such as the UK and USA are concerned. Focus is switching to growth markets such as France, Spain, Brazil and Italy where significant double-digit growth is forecast to 2011. With business cycles growing shorter and shorter, market entry is quicker and more reliable through acquisition and partnering.

Drivers for change
In addition to ongoing expansion, there are other drivers which are causing the generic companies to consider the future:

The number of new generic drug opportunities are reducing in line with the decline in NDAs over recent years. Furthermore, the branded industry is far more aware of the potential to protect revenues by issuing early branded generics and/or new formulations.

The increasing introduction of biotech based products will present regulatory and production hurdles to generic manufacturers in the future.

Identify new business opportunities and assess risk
For everyone needing to evaluate the generic industry's competitive landscape this new, thoroughly researched 350-page report Emerging Generic Drug Companies Worldwide 2007 (Published February 2007) is essential reading.
Unbeatable coverage

For each company where available or appropriate

BACKGROUND
A summary of the company's foundation and main business interests

PRODUCT RANGE
Details of ANDAs approved or products represented

FINANCIAL
Financial performance or funding data

STRATEGIC ALLIANCES
Details of significant marketing and supply agreements

CONTACT INFORMATION

Use this report to…

Identify commercial partners

Understand the developing generic industry in key markets worldwide

Profile the competitive environment in the increasingly important medium sized company sector

Seek out companies manufacturing/marketing similar product lines

Assess the investment potential of these developing companies

145 companies from 37 countries evaluated

Abdi Ibrahim
Abraxis BioScience
Abrika Pharmaceuticals
Ache
Adcock Ingram
Akorn
Akrikhin
Akyma Pharmaceuticals
Alembic
Alternova
Amphastar Pharmaceuticals
Andromaco
Antibiotice
Aurobindo Pharma
Australian Pharmaceutical Industries
Banner Pharmacaps
Bedford Laboratories
Belupo
Bentley Pharmaceuticals
Bestpharma
Beximco Pharma
Bilim Pharmaceuticals
Biocon
Biogaran
Biolab
Bio-nucleonics Pharma
Biosano
Biosintetica
Biotika
Boca Pharmacal
Bryntsalov
Calox
Caraco Pharmaceutical Laboratories
Carolina Medical Products Company
CCL
Cedar Pharmaceuticals
Cedarburg Pharmaceuticals
Cimed
Cofasa
Consilient Health
Copyfarm
CorePharma
Cristalia
Dr Raza Pharma
Ecar
EIPICo
Elter
EMS-Sigma
Enaleni Pharmaceuticals
Epla Labs
Erka farm
Eurand
Eurofarma
Europharm
Farmacon
Farmasa
Farmindustria
Ferndale Laboratories
Fleming & Company Pharmaceuticals
Fougera
G&W Laboratories
GeneMedix
Genepharm
Genfar
Glades Pharmaceuticals
Glenmark Pharmaceuticals
Goldshield
Grindeks
Hamilton Laboratories
Hanford Manufacturing
Harmony Labs
Highnoon Laboratories
Hikma
Hi-Tech Pharmacal
Hovione FarmaCiencia
Impax Laboratories
Infarmasa
Inno Biologics
Interpharm
Invagen Pharmaceuticals
JB Chemicals & Pharmaceuticals
Jubilant Organosys
Kent Pharmaceuticals
Kimia
Kimiceg
Kremers Urban Development Company
KV Pharmaceutical
La Sante
Labopharm
Laboratorios Kendrick
Laboratorios Silanes
Laboratorios Stein
Lafrancol
Leti
Libbs Farmaceutica
Luitpold Pharmaceuticals
Lupin Laboratories
Lyne Laboratories
Mallinckrodt
Matrix Laboratories
Maver
Medley
Mepha Pharma
Meyer
Mikart
Mintlab
MN Pharmaceuticals
Morton Grove Pharmaceuticals
Natco Pharma
Neil Laboratories
Nephron Pharmaceuticals
Orbus
Orchid Chemicals & Pharmaceuticals
Osmotica Pharmaceutical
Paddock Laboratories
Parenta Pharmaceuticals
Pharmaceutical Associates
Prometheus Laboratories
ProStrakan
Recip, ab
Rosemont Pharmaceuticals
Roxane Laboratories
RxElite
Sanitas
Sigma Pharmaceuticals
Silarx Pharmaceuticals
Sopharma
Spear Pharmaceuticals+M68
Spectrum Pharmaceuticals
Spirig
Stiefel Laboratories
Streuli
Strides Arcolab
Sun Pharmaceutical Laboratories
Supergen
Tabuk Pharmaceutical
Taro Pharmaceutical Industries
Three Rivers Pharmaceuticals
Unipharm
United Research Laboratories/ Mutual Pharmaceutical
Upsher-Smith Laboratories
Veropharm
Vista Pharmaceuticals
Vistapharm
X-Gen Pharmaceuticals